Bharat Biotech: Covaxin phase-3 results show interim efficacy of 81%
Zee Business Video Team | Updated: March 3, 2021 08:03 PM IST
Bharat Biotech on Wednesday announced the phase 3 results of its coronavirus vaccine ‘Covaxin’ claiming the shots have demonstrated an interim clinical efficacy of nearly 81%.